-- Days : -- HRS : -- MIN : -- SEC

Register for Free →

News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach

Participating Faculty

By

April 1st 1998

Introduction: Clinical and Economic Considerations of Coronary Heart Disease: A Managed Care Approach

By

April 1st 1998

Coronary Heart Disease in the United States

ByGrant D. Lawless, MD

April 1st 1998

Mechanisms of Acute Coronary Events

ByDaniel J. Rader, MD

April 1st 1998

Primary Prevention

ByStuart M. Cobbe, MD

April 1st 1998

Pravastatin Event Reduction Analysis

ByJames Shepherd, MD, PhD

April 1st 1998

Secondary Prevention

ByJohn S. Banas, Jr., MD

April 1st 1998

Point/Counterpoint: Is LDL-C Reduction the Outcome of Choice?

ByWilliam P. Castelli, MD,W. Virgil Brown, MD,Evan A. Stein, MD, PhD,James Shepherd, MD, PhD

April 1st 1998

Methods and Mindsets in Pharmacoeconomics

ByWilliam F. McGhan, PharmD, PhD

April 1st 1998

Issues and Controversies in Pharmacoeconomics

ByWilliam F. McGhan, PharmD, PhD,James M. McKenney, PharmD,Susan Andrade, ScD,Sidney C. Smith, Jr, MD,Bruce Kinosian, MD,Joel W. Hay, PhD

April 1st 1998

Pharmacoeconomics Perspectives: Payers, Providers, and Patients

ByPaul C. Langley, PhD,Nicolaas Otten, PharmD,Peter Davey, MD,James C. Bonnette, MD,J. Russell Teagarden,William F. McGhan, PharmD, PhD

April 1st 1998

Assessing the Value and Affordability of Cholesterol Reduction in the Managed Care Setting

ByEdgar R. Gonzalez, PharmD,Barbara S. Kannewurf, RPh

April 1st 1998

CME Quiz

By

April 1st 1998

Selected Abstracts

By

April 1st 1998

Bibliography

By

April 1st 1998

Part I: Scope of the Problem

By

April 1st 1998

Part II: Primary Prevention

By

April 1st 1998

Part III: Secondary Prevention

By

April 1st 1998

Part IV: Pharmacoeconomics

By

April 1st 1998

Trending on AJMC

Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%

Pulmonary Embolism Can Affect Elite Athletes, Too: Samantha Pettigrew, MD

Uninsured Rate Rises to 11.2% as Coverage Erodes Before Medicaid Cuts

UPMC Health Plan's Food as Medicine Pilot for Members With Diabetes

Insurance Barriers Tied to Missed Long-Acting PrEP Starts